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EDITORIAL
New insights into the pathogenesis of
membranous nephropathy
Membranous nephropathy (MN) is a leading cause of ing these animals with antioxidants significantly reduces
nephrotic syndrome in adults. The target of injury in the proteinuria [5]. Proteinuria may also be due to a
MN is the glomerular visceral epithelial cell or podocyte, C5b-9 induced increase in specific proteinases (gelatinase
a highly specialized and terminally differentiated cell and metalloproteinase-9) [6]. The characteristic thick-
that rests on the outside of the glomerular basement ening of the glomerular basement membrane in MN is
membrane. Proteinuria follows the formation of subepi- due to the accumulation of extracellular matrix proteins.
thelial deposits, which is associated with podocyte flat- Studies have shown that specific isoforms of trans-
tening and effacement. With time, there is thickening of forming growth factor-b (TGF-b) and their receptors are
the glomerular basement membrane (GBM) due to an potential mediators of matrix accumulation in Heymann
increase in the accumulation of extracellular matrix pro- nephritis [7]. In contrast to the mesangial and endothelial
tein synthesis by podocytes. cells, podocytes do not readily undergo proliferation in
In an attempt to develop specific therapy for MN, response to immune-mediated injury, but rather hyper-
researchers have focused on the rat model of passive trophy. The apparent inadequate proliferative response
Heymann nephritis, because it closely resembles many may underlie the development of progressive glomerulo-
of the features of the human disease [1]. Because the sclerosis in certain forms of glomerular disease. Recent
presence of subepithelial deposits suggested to research- studies have shown that the expression of specific cell
ers early on that MN is an immune-mediated disease, cycle proteins are altered following C5b-9 attack on po-
the first area of search was to identify the antigen(s) docytes in vitro and in vivo, and that these prevent the
responsible for the membranous lesion. After many proliferative response of podocytes to C5b-9-mediated
years, Kerjaschki, Farquahar and others have identified injury [8, 9].
the antigen as the Megalin-receptor associated protein There is a growing body of literature showing that the
complex in experimental MN [2]. However, at this time response to C5b-9 injury is not merely due to the creation
the identification of the human antigen remains elusive. of holes in the cell membrane, but rather are due to
A second major area of research has been the recognition the activation of specific signal pathways. Thus, sublytic
that antibody binding to the membranous antigen acti- C5b-9 activates the phospholipase C, protein kinase C
vates complement, leading to the insertion of C5b-9 and extracellular signal-regulated kinase-2 signal path-
(membrane attack complex) into the podocyte plasma ways [10]. Why did Cybulsky et al study phospholipase
membrane [3]. Over the past 10 years studies have clearly A2 (PLA2) [4], an enzyme that releases free arachidonic
documented a critical role for C5b-9-induced podocyte acid from phospholipids? Arachidonic acids are precur-
injury leading to the development of proteinuria. sors for the synthesis of eicosanoids (prostaglandins,
The third area of research is to delineate the mecha- thromboxanes, leukotrienes), which are increased in the
nisms underlying the podocyte’s response to C5b-9 in- passive Heymann nephritis model. Furthermore, inhib-
jury, which include hypertrophy, matrix production, and iting specific eicosanoids has confirmed their role in the
the maintenance of a well-differentiated and quiescent development of proteinuria and increased intraglomeru-
phenotype, and to determine how these events translate lar pressures in MN [11–15]. In their current study, Cy-
into proteinuria and progressive glomerulosclerosis. In bulsky and colleagues show that cytoplasmic PLA2, but
this regard, Cybulsky and colleagues have provided new not the soluble PLA2 isoform, was activated by C5b-9insights into the regulation of phospholipase A2 (PLA2) in podocytes in culture, and also in the glomeruli of rats
in the podocytes in response to C5b-9-induced injury [4]. with experimental membranous nephropathy [4]. This
Previous studies showed that C5b-9 activates the release was not associated with an increase in gene expression
of oxidants in passive Heymann nephritis, and that treat- for either the cytoplasmic or soluble PLA2 isoforms. This
study thus provides further insights into the complexities
of C5b-9-induced injury to podocytes, and also into theKey words: podocyte, membranous nephropathy, C5b-9, complement,
glomerular epithelial cell. pathogenesis of MN. Perhaps reducing phospholipase
activity may be another potential way of interruptingÓ 2000 by the International Society of Nephrology
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